# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Lake Street analyst Ben Haynor maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $37 to $34.
Stifel analyst Rick Wise maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $32 to $20.
JMP Securities analyst David Turkaly maintains OrthoPediatrics (NASDAQ:KIDS) with a Market Outperform and lowers the price t...
Piper Sandler analyst Matt O'Brien maintains OrthoPediatrics (NASDAQ:KIDS) with a Overweight and lowers the price target...
BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $39 to $23.